ARTH - Arch Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue9/30/20189/30/20179/30/20169/30/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development2,884.2452,094.7951,683.2991,760.037
Selling General and Administrative4,565.5225,207.7534,367.4763,700.477
Non Recurring----
Others----
Total Operating Expenses7,449.7677,302.5486,050.7755,460.514
Operating Income or Loss-7,449.767-7,302.548-6,050.775-5,460.514
Income from Continuing Operations
Total Other Income/Expenses Net2,635.735-486.30858.4052,512.988
Earnings Before Interest and Taxes-7,449.767-7,302.548-6,050.775-5,460.514
Interest Expense--52.385-276.687-377.805
Income Before Tax-4,814.032-7,788.856-5,992.37-2,947.526
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-4,814.032-7,788.856-5,992.37-2,947.526
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-4,814.032-7,788.856-5,992.37-2,947.526
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-4,814.032-7,788.856-5,992.37-2,947.526